CoChat

New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment

Open access
Makhaeva, Galina F., Kovaleva, Nadezhda V., Boltneva, Natalia P., Lushchekina, Sofya V., Astakhova, Tatiana Yu., Rudakova, Elena V., Proshin, Alexey N., Serkov, Igor V., Radchenko, Eugene V., Palyulin, Vladimir A., Bachurin, Sergey O., Richardson, Rudy J. · 2020 · Molecules

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Abstract

New hybrid compounds of 4-amino-2,3-polymethylene-quinoline containing different sizes of the aliphatic ring and linked to p-tolylsulfonamide with alkylene spacers of increasing length were synthesized as potential drugs for treatment of Alzheimer’s disease (AD). All compounds were potent inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with selectivity toward BChE. The lead compound 4-methyl-N-(5-(1,2,3,4-tetrahydro-acridin-9-ylamino)-pentyl)-benzenesulfonamide (7h) exhibited an IC50 (AChE) = 0.131 ± 0.01 µM (five times more potent than tacrine), IC50(BChE) = 0.0680 ± 0.0014 µM, and 17.5 ± 1.5% propidium displacement at 20 µM. The compounds possessed low activity against carboxylesterase, indicating a likely absence of unwanted drug-drug interactions in clinical use. Kinetics studies were consistent with mixed-type reversible inhibition of both cholinesterases. Molecular docking demonstrated dual binding sites of the conjugates in AChE and clarified the differences in the structure-activity relationships for AChE and BChE inhibition. The conjugates could bind to the AChE peripheral anionic site and displace propidium, indicating their potential to block AChE-induced β-amyloid aggregation, thereby exerting a disease-modifying effect. All compounds demonstrated low antioxidant activity. Computational ADMET profiles predicted that all compounds would have good intestinal absorption, medium blood-brain barrier permeability, and medium cardiac toxicity risk. Overall, the results indicate that the novel conjugates show promise for further development and optimization as multitarget anti-AD agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules25173915

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structures of pharmacophores: (A) 4-amino-2,3-polymethylene-quinolines; (B) p-tolylsulfonamide.
Figure 1 Structures of pharmacophores: (A) 4-amino-2,3-polymethylene-quinolines; (B) p-tolylsulfonamide.CC BY · PubMed Central
Figure 2 Synthesis of conjugates of 4-amino-2,3-polymethylene-quinolines and p-tolylsulfonamide 7.
Figure 2 Synthesis of conjugates of 4-amino-2,3-polymethylene-quinolines and p-tolylsulfonamide 7.CC BY · PubMed Central
Figure 3 Steady state inhibition of (A) AChE and (B) BChE by compound 7g. Lineweaver-Burk double-reciprocal plots of initial velocity and substrate concentrations in the presence of inhibitor (three concentrations) and without inhibitor are presented. The changes in both Km and Vmax attest to a mixed type of inhibition.
Figure 3 Steady state inhibition of (A) AChE and (B) BChE by compound 7g. Lineweaver-Burk double-reciprocal plots of initial velocity and substrate concentrations in the presence of inhibitor (three concentrations) and without inhibitor are presented. The changes in both Km and Vmax attest to a mixed type of inhibition.CC BY · PubMed Central
Figure 4 Results of molecular docking of hybrids of 4-amino-2,3-polymethylene-quinoline and p-tolylsulfonamide 7 into AChE (carbon atoms are shown in pale blue) and BChE (carbon atoms are shown in orange). The surface shows the gorge leading from the protein surface to the active site with a hollow space accommodating the aliphatic ring of the tacrine fragment of compounds 7. Compounds 7b, 7f, 7i, 7k with m = 3 spacers and increasing aliphatic ring size (carbon atoms are shown with different shades of red from pale for 7b (C-5) to bright for 7k (C-8) inside (A) AChE and (B) BChE. Compounds 7a–7e with C-5 aliphatic rings and increasing spacer length (carbon atoms are shown with different shades of green from pale for 7a (m = 2) to dark for 7e (m = 6) inside (C) AChE and (D) BChE.
Figure 4 Results of molecular docking of hybrids of 4-amino-2,3-polymethylene-quinoline and p-tolylsulfonamide 7 into AChE (carbon atoms are shown in pale blue) and BChE (carbon atoms are shown in orange). The surface shows the gorge leading from the protein surface to the active site with a hollow space accommodating the aliphatic ring of the tacrine fragment of compounds 7. Compounds 7b, 7f, 7i, 7k with m = 3 spacers and increasing aliphatic ring size (carbon atoms are shown with different shades of red from pale for 7b (C-5) to bright for 7k (C-8) inside (A) AChE and (B) BChE. Compounds 7a–7e with C-5 aliphatic rings and increasing spacer length (carbon atoms are shown with different shades of green from pale for 7a (m = 2) to dark for 7e (m = 6) inside (C) AChE and (D) BChE.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 113 references

Cited by

See all 54

Metadata

Authors
Makhaeva, G. F., Kovaleva, N. V., Boltneva, N. P., Lushchekina, S. V., Astakhova, T. Y., Rudakova, E. V., Proshin, A. N., Serkov, I. V., Radchenko, E. V., Palyulin, V. A., Bachurin, S. O., & Richardson, R. J.
Affiliations
  • Institute of Physiologically Active Compounds, Russian Academy of Sciences, 142432 Chernogolovka, Russia
  • Russian Academy of Sciences (RU)
  • University of Michigan (US)
Corresponding author
Richardson, Rudy J.
Venue
Molecules
Publisher
MDPI AG
Published
2020-08-27
Volume
25
Issue
17
Pages
3915
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3080321652
Cited by
53
References
113
Citations by year
2026: 11 · 2025: 10 · 2024: 6 · 2023: 10 · 2022: 6 · 2021: 6 · 2020: 4
FWCI
3.90
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Russian Foundation for Basic Research (19-53-26016_a)
  • IPAC RAS State Targets Project (0090-2019-0005)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
acetylcholinesterase inhibitors, butyrylcholinesterase inhibitors, Alzheimer's disease, structure-activity relationship, peripheral anionic site, amyloid-beta aggregation, ADMET prediction, molecular docking
MeSH terms
Alzheimer Disease, Antioxidants, Cholinesterase Inhibitors, Drug Interactions, Humans, Models, Molecular, Quinolines, Structure-Activity Relationship, Sulfonamides, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment. https://app.cochat.ai/papers/10.3390/molecules25173915
The paper
Makhaeva, G. F., Kovaleva, N. V., Boltneva, N. P., Lushchekina, S. V., Astakhova, T. Y., Rudakova, E. V., Proshin, A. N., Serkov, I. V., Radchenko, E. V., Palyulin, V. A., Bachurin, S. O., & Richardson, R. J. (2020). New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment. Molecules. https://doi.org/10.3390/molecules25173915

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.